Canada: What Federal Legalization Looks Like 4 years Later and What Have We Learned

Sherri Altshuler Related Seminars and Products

Partner

Aird & Berlis LLP

Sherri earns the trust of her clients by adeptly managing complex and time-sensitive corporate finance transactions and by providing relevant, business-focused solutions to corporate/commercial and capital markets issues. Her depth of perspective and understanding of corporate and securities law matters comes from her ongoing representation of clients ranging from small and medium enterprises to established multi-billion dollar corporations. Sherri effectively prioritizes issues on complex and time-sensitive transactions, and works diligently to ensure that outcomes align with her clients’ overall business goals.

Sherri is co-Practice Group Leader of the firm's Capital Markets Group, co-Chair of the Cannabis Group and Life Sciences Group and a member of the Corporate/Commercial, Mining, Capital Pool Company and Startups Groups. Her practice is focused on mergers, acquisitions, corporate reorganizations, public and private financings and ongoing corporate and commercial matters. She has developed specialized expertise in capital markets transactions in the REIT, cannabis, technology, psychedelics and mining sectors, including with respect to board governance, securities and financing matters.

Sherri regularly advises corporations on public offerings, private placement financings, flow-through financings, reverse takeovers, stock exchange listings, continuous disclosure, corporate governance and the formation and completion of qualifying transactions for companies established under the TSX Venture Exchange Capital Pool Company Program.

Sherri is a member of the TSX Venture Exchange Ontario Advisory Committee and a former member of the Ontario Securities Commission Small and Medium Enterprises Committee. Sherri previously completed a six-month term of secondment with the Corporate Finance Branch of the Ontario Securities Commission where she was responsible for reviewing and clearing prospectuses and considering applications for relief from the requirements of the Securities Act (Ontario). Sherri also instructs Corporate Finance at Windsor Law School and is a frequent public speaker. Additionally, Sherri is called upon by the media to comment on the legal, regulatory and investment issues surrounding psychedelics in Canada.

Sherri is recognized by The Canadian Legal Lexpert Directory as a leading lawyer in the area of Corporate Finance & Securities, after previously being named one of Lexpert magazine’s Rising Stars: Canada’s Leading Lawyers under 40. Sherri is also recognized as a leading lawyer in Cannabis Law by Chambers Canada and The Best Lawyers in Canada.

Jason Moscovici Related Seminars and Products

Partner, Lawyer, Biochemist

Robic, LLP

Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.

Jonathan Sherman Related Seminars and Products

Partner & Co-Chair of the Cannabis Group

Cassels Brock & Blackwell LLP

Jonathan Sherman is a partner in the Securities Group at Cassels Brock & Blackwell LLP, serving as Co-Chair of the Cannabis Group and as a member of the firm’s Executive Committee. Jonathan’s practice focuses on emerging and high-growth industries, including cannabis, technology, natural resources, beverage alcohol, gaming, blockchain, cryptocurrency and psychedelic medicines. In his role as Co-Chair of the firm’s Cannabis Group, Jonathan is at the forefront of many of the largest industry transactions in this evolving sector, providing strategic and legal advice to a range of leading industry players on complex and innovative transactions.

Jonathan acts for a wide variety of domestic and international companies and investment banks. With corporate clients ranging from startups to multibillion-dollar businesses, Jonathan’s practice focuses on mergers and acquisitions (public and private acquisitions, business combinations, joint ventures, go-public transactions and strategic collaborations) and corporate finance transactions (public offerings, venture capital, private equity offerings and debt financing transactions).

Whether strategically guiding clients through M&A, or helping emerging start-ups secure investments, Jonathan has become a trusted advisor to many. In addition, he has played a central role on several of the largest transactions completed to-date in the cannabis industry. He acts for industry-leader Canopy Growth on corporate, commercial, securities and M&A matters, including numerous M&A transactions valued at over $5 billion, a $600 million offering of senior convertible unsecured notes, a US$1.25 billion senior secured debt financing and various innovative cross-border transactions to facilitate Canopy Growth’s conditional exposure to the United States cannabis market in advance of federal legalization.